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Abstract
Background: Premacular subhyaloid hemorrhage results in a sudden profound loss of vision. Among the
modalities for its treatment, Nd:YAG laser hyaloidotomy is a non invasive method enabling rapid drainage of the
obstructed macular area and improved vision within days. This study was aimed to evaluate the efficacy, visual
outcome and complications following Nd:YAG laser hyaloidotomy for premacular subhyaloid hemorrhage.
Methods: Patients with premacular subhyaloid hemorrhage of more than 3 disc diameters (DD) of various
etiologies, attending Tilganga Institute of Ophthalmology, Nepal from August, 2014 to February, 2015, were
included. A comprehensive ocular evaluation was conducted and fundus photographs were taken to measure the
size of the subhyaloid hemorrhage. Optical coherence tomography (OCT) were performed before and after
treatment and on subsequent follow up visits. Fundus fluorescence angiography was done whenever necessary. Q
switched Nd:YAG laser was applied to create an opening in the posterior hyaloids membrane for draining
subhyaloid hemorrhage. The main outcome measures were success rate in performing hyaloidotomy, drainage of
subhyaloid blood into vitreous cavity and its resorption, improvement in visual acuity, need for further intervention
and postoperative complications.
Results: There were 21 eyes of 19 patients, 17(89.48 %) male and 2(10.52 %) female. In 3, premacular subhyaloid
hemorrhage was bilateral. Mean age was 41.68 ± 17.08 years and a mean duration of symptoms 15.04 days. Mean
pretreatment hemorrhage was 6.27DD. Nd:YAG laser hyaloidotomy was successful in 19 eyes(86.4 %). In 2 patients,
one each with Eales’ disease and retinal vein occlusion the procedure was unsuccessful, necessitating pars plana
vitrectomy, while in a case with proliferative diabetic retinopathy (PDR), vitrectomy was resorted for non clearing
vitreous hemorrhage. Vision improved from a median of 3/60 pre-operatively to 6/6, at 6 months follow up. At
3 months, 2 patients with Eales’ disease, one developed tractional detachment at macula while the other, an
epiretinal membrane. No other complications were noted at 6 months.
Conclusion: Nd:YAG laser hyaloidotomy is an inexpensive, effective and a safe outpatient procedure for premacular
subhyaloid hemorrhage, producing rapid drainage with restoration of visual function avoiding more invasive
procedures and enabling early assessment of the underlying retina. The final visual prognosis however, rests on the
underlying cause of the subhyaloid hemorrhage and any accompanying retinal changes.
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Background
Subhyaloid hemorrhage is a localized detachment of the
vitreous from the retina due to the accumulation of blood
[1]. When localized in the macular area, it results in sud-
den profound loss of vision. Subhyaloid premacular
hemorrhage is typically characterized by a circumscribed,
round or dumb-bell shaped, bright red mound of blood
beneath the internal limiting membrane (ILM) or between
the ILM and hyaloid face, in or near to the central macu-
lar area [2, 3]. It may occur in retinal vascular disorders,
such as proliferative diabetic retinopathy [4], retinal vein
occlusion [5], macroaneurysm [4], age-related macular de-
generation [5] and arterio-venous communication of the
retina; [6] hematological disorders as aplastic anemia and
leukemia; [7] following laser in situ keratomileusis (LA-
SIK); [8] or after retinal vascular rupture associated with
physical exertion (valsalva) [2, 9–11], Terson’s syndrome
[12] and Purtscher’s retinopathy [13]. Though spontan-
eous resolution occurs in most cases, this process takes
several weeks or months depending on the thickness and
total amount of blood present, often incapacitating to the
patient when occurring bilaterally or in a one eyed pa-
tients. Moreover, it may result in permanent visual impair-
ment due to pigmentary macular changes or formation of
epiretinal membranes and toxic damage to the retina due
to prolonged contact with hemoglobin and Iron [14].
Various techniques have been described to treat
premacular subhyaloid hemorrhage. These include, ob-
servation, Nd:YAG laser hyaloidotomy [15], pneumatic
displacement of hemorrhage by intravitreal injection of
gas and tissue plasminogen activator [16] and pars plana
vitrectomy [17]. Puncturing the posterior hyaloid face
with Nd:YAG or green argon laser is a non invasive
method, which enables the drainage of the extensive pre-
macular subhyaloid hemorrhage into the vitreous, facili-
tates absorption of blood cells and improves vision
within days by clearance of the obstructed macular area.
In this study, we describe the etiologies, patient charac-
teristics and outcome of Nd:YAG laser hyaloidotomy in
22 eyes of 19 patients presenting with premacular sub-
hyaloid hemorrhage.
Methods
This nonrandomized prospective interventional case
series included patients with subhyaloid premacular
hemorrhage of various etiologies attending Tilganga In-
stitute of Ophthalmology, Nepal from August, 2014 to
February, 2015. Only those patients with subhyaloid
hemorrhage more than 3 disc diameters (DD) (by ap-
proximation and measured by the same person) and
without significant vitreous opacities precluding the use
of Nd:YAG laser, were included. Pretreatment and post-
treatment assessment, conducted by trained retina spe-
cialists, included best corrected visual acuity (Snellen
chart), slit lamp biomicroscopic examination with +90D
(Volk) lens, intraocular pressure and fundus evaluation.
Fundus photographs were taken to measure the size of
the subhyaloid hemorrhage by comparing with disc di-
mensions. The horizontal and vertical diameters of the
preretinal hemorrhage were measured in DD and aver-
aged. Optical coherence tomography (OCT) were per-
formed before and after treatment and on subsequent
follow up visits. Fundus fluorescence angiography was
performed whenever necessary.
After detailed discussion of management options, the
procedure was explained to the patient and consent ob-
tained. Mydriasis was achieved with tropicamide 0.5 %
eye drop and topical anesthesia with lignocaine 4 % eye
drops. Q switchedNd:YAG laser (Ellex Super Q, Ellex,
USA) emitting single burst was delivered through a slit
lamp delivery system using Goldman three mirror con-
tact lens (Volk) to create an opening in the posterior
hyaloid membrane near the inferior edge of the subhya-
loid hemorrhage, avoiding retinal blood vessels and fovea
but keeping a reasonably sufficient underlying cushion
of blood to shield the underlying retina. Laser exposures
were started with 5mj and then gradually increased 1mj
each, until a perforation became visible at the surface
and blood drainage under gravity into the vitreous cavity
was evident. In those cases, where blood did not drain
even after 8 shots, the procedure was abandoned. Pa-
tients were followed at 1 week, 6 weeks, 3 months and
6 months period.
The main outcome measures were success rate in per-
forming hyaloidotomy, drainage of subhyaloid blood into
vitreous cavity and its resorption, improvement in visual
acuity, need for further intervention and postoperative
complications. Institutional review board of Tilganga In-
stitute of Ophthalmology approved this study.
Results
This study included twenty-two eyes of nineteen patients
with premacular subhyaloid hemorrhage, 17 (89.48 %)
were male and 2 (10.52 %) were female. In three patients
premacular subhyaloid hemorrhage was bilateral. Mean
age of the participants was 41.68 ± 17.08 years (range
18–76 years) with a mean duration of symptoms
15.04 days (range 1–49 days). Etiologies of premacular
subhyaloid hemorrhage in 22 eyes were noted as valsalva
retinopathy in 5 (22.72 %) [Fig. 1], ruptured retinal ar-
tery macroaneurysm in 2 (9.09 %) [Fig. 2], Eales’ disease
in 5 (22.72 %) [Fig. 3a], Terson’s syndrome in 1 (4.54 %),
proliferative diabetic retinopathy (PDR) in 4 (18.18 %),
leukemic retinopathy in 2 (9.09 %) [Fig. 4], high altitude
retinopathy in 1 (4.54 %) [Fig. 5], choroidal neovascular
membrane (CNVM) in 1 (4.54 %) [Fig. 6] and branch
retinal vein occlusion in 1 (4.54 %). The mean pretreat-
ment hemorrhage as judged by fundus photography was
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6.27 disc areas. Most of the cases of Valsalva retinopathy
showed sub-ILM bleed [Fig. 7a] and one with true sub-
hyaloid hemorrhage. One patient with Eales’ disease had
both sub-ILM and subhyaloid component. Fundus fluor-
escence angiography was carried out in few patients for
diagnostic purpose and for monitoring of therapeutic re-
sponses [Fig. 3e & f].
Preoperative visual acuity ranged from hand motion to
6/60. The mean number of laser shots were 2.5 (range
1–8) and the mean energy required to perform posterior
hyaloidotomy was 6.54mj. After 1 week, visual acuity
ranged from hand motion to 6/6 (Median 6/18), at
6 weeks follow up visual acuity ranged from hand mo-
tion to 6/6 (Median 6/9) and at 3 and 6 months follow
up visual acuity ranged from 6/24 to 6/6 (Median 6/6).
Nd-YAG laser hyaloidotomy with drainage of premacu-
lar subhyaloid hemorrhage was successful in 19 out of
22 eyes (86.4 %). In two patients, one with Eales’ disease
(case 3) and the other with retinal vein occlusion (case
12), Nd:YAG laser hyaloidotomy was not able to drain
subhyaloid hemorrhage necessitating pars plana vitrec-
tomy while in a case with PDR (case 6), vitrectomy had
to be performed for non clearing vitreous hemorrhage.
During 6 weeks follow up, a patient with Eales’ disease
(case 13), who had successful drainage of subhyaloid
blood in the vitreous cavity, laser opening clinically evi-
dent on fundus evaluation, later developed tractional de-
tachment at macula due to regressing neovascularisation
frond, requiring pars plana vitrectomy [Fig. 3]. Addition-
ally, an epiretinal membrane developed in a patient with
Eales’ disease (case 17). No other complication including
increase in intraocular pressure, retinal and choroidal
hemorrhage, macular hole or retinal break formation
was noted. Table 1 summarizes patients’ characteristics
and post operative results.
Interestingly, apart from a case of high altitude retin-
opathy (case 15) included in the series, we observed 2
more cases of premacular subhyaloid hemorrhage ( <3
DD) with high altitude exposure. All the three patients
had returned from expedition to the Everest Base Camp
in Nepal (at an altitude of 5364 metres).
As the size of the hemorrhage was less than 3 DD in
the latter 2 patients, after explanation of the manage-
ment options, they opted for a conservative approach.
Unfortunately, they were visitors to Nepal and they
returned to their respective countries, with no available
further data. Table 2 describes characteristics of patients
with high altitude exposure.
Discussion
Premacular subhyaloid hemorrhage produces sudden
profound loss of vision that may be prolonged if un-
treated [1, 9]. Various therapeutic options are available
including observation, pneumatic displacement, vitrec-
tomy and Nd:YAG laser hyaloidotomy. Spontaneous re-
sorption of blood entrapped in the subhyaloid space
A B C
Fig. 1 Color fundus photographs of a patient with Valsalva retinopathy. a Demonstrating boat shaped hemorrhage. b Same patient immediately
after Nd: YAG laser hyaloidotomy. Note the draining premacular hemorrhage. c Fundus picture after 6 weeks
A B C
Fig. 2 Color fundus photographs of a patient with ruptured macroaneurysm. a Before treatment. Note the macroaneurysm in superotemporal
quadrant. b Immediately after Nd:YAG photodisruption with blood draining into vitreous cavity inferiorly (c). Resolving hemorrhage after 1 week
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may take few weeks to several months. A slowly resolv-
ing subhyaloid hemorrhage might cause permanent vis-
ual loss due to pigmentary macular changes or growth
of epiretinal membrane, and also prolongs the contact of
the retina with blood, hemoglobin and iron, possibly
causing toxic damage to the retina and reducing visual
function, which may be irreversible [18, 19]. Early treat-
ment allows rapid restoration of vision and visualization
of the macular area with expedited access for fluorescein
angiography and macular photocoagulation. Moreover, a
quick recovery from this incapacitating vision deprivation
is desired by most patients owing to their younger age.
This becomes particularly important for one eyed patients,
patient with poor vision in their fellow eye or in bilateral
cases.
Nd:YAG laser assisted drainage of a premacular
subhyaloid hemorrhage and subinternal limiting mem-
brane (ILM) hemorrhage was described in the 1980’s
[15, 20]. Since then, there have been various studies
describing this procedure with varying degree of suc-
cess. Timing is quite crucial, for successful drainage
of blood through hyaloidotomy opening. Previous
studies have shown that the premacular hemorrhage
may clot [7, 8, 10, 21] or may re-bleed after success-
ful drainage [7]. In this series, despite a successful open-
ing in the posterior hyaloid, premacular hemorrhage in a
patient with Eales’ disease and in the other with retinal
vein occlusion, failed to drain into the vitreous, necessitat-
ing a pars plana vitrectomy. Notably, these patients had
premacular hemorrhages greater than 10 discs diameter in
size, suggesting that the size of the hemorrhage as a prog-
nostic factor for the success of the procedure. In the stud-
ies those achieved successful drainage of premacular
hemorrhage, visual acuity improved within days in most
of the patients, the degree of improvement depended on
the underlying and pre-existing macular damage [9, 15,
17, 18]. As in the previous studies [10, 11, 22, 23], valsalva
retinopathy and Terson’s syndrome in this series showed
CA B
D E F
Fig. 3 Color fundus photographs of a patient with Eales’ disease. a At the time of presentation. b Note the liquefied blood with neovascularisation of the
disc. c Patient after Nd:YAG laser hyaloidotomy. Note the draining blood. d 6 weeks after hyaloidotomy. Note the tractional detachment at macula due to
regressing neovascular frond (Blue arrow) and hyaloidotomy opening (Red arrow). e Fundus flurescein angiography (FFA) showing hyperflurescence due to
neovascularisation of the disc. f Late phase FFA of the same patient with characteristic leakage of dye
A B C
Fig. 4 Color fundus photographs of a patient with leukemic retinopathy. a With multiple nerve fiber layer hemorrhage. b Immediately after Nd:YAG
hyaloidotomy with two openings. c Day 1 after laser, with clearing premacular bleed
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the best results owing to the lack of underlying pathology.
Additionally, in this study, a patient with high altitude ret-
inopathy showed good improvement in visual acuity and
we had also observed premacular subhyaloid hemorrhage
in 2 more patients who had a history of ascension to high
altitude. We were not able to find any study describing
this as an etiology and the role of Nd:YAG laser hyaloidot-
omy in the management of this condition.
Two patients with ruptured macroaneurysm in this
series did not gain complete visual recovery owing to the
associated macular pathology, a finding consistent with
the study of Ahmadabadi [12]. Patient with leukemic ret-
inopathy and CNVM did well with Nd:YAG laser hyaloi-
dotomy however, patient with CNVM required several
doses of intravitreal Bevacizumab following successful
Nd:YAG laser [7]. Premacular subhyaloid hemorrhage as-
sociated with PDR yielded mixed results, consistent with
the study of Ahmadabadi [12]. Among the patients with
subhyaloid hemorrhage with PDR, three achieved im-
provement in visual acuity, while in one Nd:YAG was not
success resorting to pars plana vitrectomy. Interestingly in
this study, two patients with symptoms of more than
45 days, Nd:YAG laser hyaloidotomy was successful to
drain premacular blood into the vitreous cavity. This sig-
nifies that the state of blood in the premacular area is im-
portant rather than the duration of symptoms. In this
study, we did not compare the success of Nd:YAG laser
hyaloidotomy with the duration of symptoms as in other
series [7, 8, 10, 12, 15, 22, 23]. In this series hyaloidotomy
was successful in 19 eyes(86.4 %) with visual improvement
in all successful cases, though a patient with Eales’ disease
after drainage of premacular hemorrhage developed trac-
tional retinal detachment at macula at 6 weeks follow up
requiring a pars plana vitrectomy with recovery to 6/6.
Ulbig et al., in their case series of 21 patients, have re-
ported a success rate of 76.2 % with good visualization
of the macula within one month [10]. Complications up
to 6 months after laser treatment in their case series,
were negligible with a retinal detachment in a myopic
patient with bilateral breaks and a single additional eye
that developed a macular hole. Probably the breaks were
secondary to myopic changes, which were not related to
the laser while the macular hole that developed in the
latter eye could be because the photodisruptive effect
might have been too near to the macula. Epiretinal
membrane formation (ERM) and contraction of ILM
can occur following laser disruption of premacular
hemorrhage. Kuruvilla et al. and Ahmadabadi et al. re-
ported formation of epiretinal membrane after laser
photodisruption [12, 22]. In this series, in patients with
Eales’ disease, one developed ERM and another trac-
tional macular detachment, 6 weeks after treatment of
premacular hemorrhage with photodisruption. Kwok et
al. on analysis of such membranes subsequently removed
surgically had found hemosiderin deposits under the
contracted ILM and fine glial ERM on the outer surface
A B C
Fig. 5 Color fundus photographs of a patient with high altitude retinopathy. a Characteristic boat shaped hemorrhage with multiple retinal hemorrhages.
b Immediately after Nd:YAG laser with blood draining into vitreous cavity. c Clearing premacular hemorrhage at the end of 1 week
A B C
Fig. 6 Color fundus photographs of a patient with CNVM. a Characteristic boat shaped hemorrhage. b Immediately after Nd Yag laser. c 3 months
later after couple of intravitreal Bevacizumab injection
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[2]. However, the authors of some series did not notice
complications 6 months after Nd:YAG laser assisted hya-
loidotomy for premacular subhyaloid hemorrhage [7, 11,
14, 23, 24].
Energy levels ranging from 2.5-50 mJ has been men-
tioned in the literature [3, 4, 7, 10–12, 15, 20, 22, 23, 25].
Gabel et al. reported use of 50 mJ energy without evidence
of retinal burn [20]. Puthalath et al. [25] reported
stretch burns to the hyaloid before YAG disruption
however, this study did not find the step necessary
for successful opening of posterior hyaloid. On ana-
lyzing the OCT, besides opening in the internal limit-
ing membrane, no damage to the underlying retina
was observed [Fig. 7], except in those cases with
Eales’ disease where we believe the formation of the
ERM and tractional macular detachment to be a part
of the natural disease process due to regressing fibro-
vascular band.
Good clinical judgment, appropriate positioning of
hyaloidotomy and use of the lowest possible energy level
seems prudent for performing Nd:YAG laser photodis-
ruption for premacular subhyaloid hemorrhage. It has
been advocated that the size of the hemorrhage less
than 3 disc diameter should not be subjected to
photodisruptive laser for safety reasons. This size
helps to increase the cushion effect of the
hemorrhage in order to avoid inadvertent retinal
damage by the photodisruptive laser [10]. There are
few universal recommendations for posterior Nd:YAG
laser hyaloidotomy. If possible, always drain from a
region distant enough from the inferior border where
there is significant hemorrhagic elevation. Further-
more, choosing a drainage area at a location away
from the fovea and major blood vessels seems sens-
ible. Depending on the location of the hemorrhage,
and to avoid fovea, it is sometimes safer to drain
blood from the lateral aspect of the hemorrhage and
position the head so that the blood will drain into
the vitreous cavity under the influence of the gravity
[22]. It is best to start the treatment using the least
amount of energy and then gradually increase the en-
ergy level until an adequate opening becomes visible.
In this study, we experienced that it was better to
start with 5 mJ energy and then gradually increase by
1 mJ each step to 12 mJ. If this energy level was not
able to produce a puncture on the surface of the sub-
hyaloid hemorrhage, it was less likely that it would
perforate with increasing energy.
Conclusion
As observed in our study, premacular subhyaloid
hemorrhage can also occur with high altitude expos-
ure, besides the other causes that have been de-
scribed. In accordance with this and previous studies,
Nd:YAG laser hyaloidotomy can be appreciated to be
an inexpensive, effective and a safe outpatient proced-
ure for the treatment of premacular subhyaloid
hemorrhage. It produces rapid drainage of blood with
restoration of visual function which would otherwise
warrant more invasive vitreoretinal procedures and its
associated serious complications. This is particularly
beneficial for patients with poor vision in the fellow
eye and patients requiring rapid visual rehabilitation
to be able to continue their work. Besides, it also al-
lows early assessment of the underlying retina with
expedited access for macular photocoagulation and
the avoidance of vitrectomy. The final visual
Fig. 7 a Optical coherence tomogram (OCT) of a patient with Valsalva
retinopathy showing hemorrhage under internal limiting membrane
(ILM). b OCT of a patient with Valsalva retinopathy 6 weeks after laser
photodisruption. Note the opening in ILM (yellow arrow). c OCT of a
patient after Nd:YAG laser hyaloidotomy. Note the defect in posterior
hyaloid membrane (yellow arrow) and the Vitreomacular traction
(red arrow)
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prognosis however, rests on the underlying cause of
the subhyaloid hemorrhage and any accompanying
retinal changes. Long term surveillance of Nd:YAG
laser treated cases and further randomized controlled
clinical trials are required to compare the treatment
with other modalities.
Ethics approval and consent to participate
This study was approved by the Research Ethics Re-
view Board of the Tilganga Institute of Ophthalmol-
ogy. A written informed consent was obtained from
all the participants after the study protocol had been
explained.
















1 week 6 weeks 3 months 6 months
1 76/M 3 Macroaneurysm LE 10 6/60 6/36 6/24 6/24 6/24 2 5,6
2 38/M 3 Valsalva
Retinopathy
LE 5 CFCF 6/36 6/6 6/6 6/6 1 5
3 30/M 2 Eales’ Disease RE ≥10 HM HM HM 6/60a 6/12a 8 5,6,7,8,9,10,11,12 PPV
4 25/M 15 Terson’s Syndrome RE 5 1/60 6/6 6/6 6/6 6/6 1 5
5 42/M 10 Valsalva
Retinopathy
LE 4 1/60 - 6/9 6/9 6/9 1 5
6 49/M 49 PDR LE 7 1/60 5/60 HM 6/60a 6/12a 6 5,6,7,8,9,10 PPV
7 44/M 14 PDR RE 5 3/60 6/18 6/18 6/18 6/18 2 5,6
18 PDR LE 7 4/60 6/9 6/9 6/9 6/9 1 5
8 37/M 1 Valsalva
Retinopathy
RE 8 HM 6/6 6/6 6/6 6/6 1 5
9 21/M 10 Eales’ Disease RE 4 6/60 6/6 6/6 6/6 6/6 1 5
10 Eales’ Disease LE 5 6/60 6/9 6/9 6/9 6/9 3 5,6,7
10 48/M 4 Valsalva
Retinopathy
LE 10 HM 6/36 6/9 6/9 6/9 1 5
11 68/F 15 Valsalva
Retinopathy
RE 5 5/60 6/24 6/6 6/6 6/6 2 5,6
12 69/M 30 Retinal vein
Occlusion
LE ≥10 CFCF HM HM 6/9a 6/9a 8 5,6,7,8,9,10,11,12 PPV
13 18/M 2 Eales’ Disease LE 8 HM 6/36 6/36 6/9a 6/9a 2 5,6 PPV
14 21/M 10 Leukemic
Retinopathy
RE 4 6/60 6/6 6/6 6/6 6/6 1 5
12 Leukemic
Retinopathy
LE 5 6/60 6/9 6/6 6/6 6/6 1 5
15 28/M 6 High Altitude
Retinopathy
RE 5 1/60 6/12 6/6 6/6 6/6 1 5
16 54/M 15 Macroaneurysm LE 8 1/60 6/18 6/18 6/18 6/18 1 5
17 21/M 45 Eales’ Disease RE 7 HM 6/24 6/18 6/12 6/12 5 5,6,7,8,9 ERM
18 48/F 45 PDR LE 8 6/60 6/18 6/18 6/18 6/18 4 5,6,7,8
19 55/M 12 CNVM LE 4 CFCF 6/36 6/36 6/12 6/12 2 5,6
M Male, F Female, RE Right Eye, LE Left Eye, DD Disc diameter, HM Hand Motion, CFCF Counting finger close to face, ERM Epiretinal membrane, PPV Pars plana
vitrectomy: a- Not analysed for outcomes of hyaloidotomy
Table 2 Characteristics of patients with high altitude exposure
Serial no Age(years)/Sex Duration (Days) Diagnosis Eye Size DD Visual acuity Remarks
1 28/M 6 High Altitude Retinopathy RE 5 1/60 Received Nd:YAG hyaloidotomya
2 25/M 6 High Altitude Retinopathy LE <3 6/60 Opted for conservative management
3 27/F 6 High Altitude Retinopathy RE <3 5/60 Opted for conservative management
M Male, RE Right Eye, LE Left Eye, DD Disc diameter; aCase no 15 in Table 1
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